Showing results (271-280 of 297) with videos related to
Sort By:
Pageof 30
Contemporary Clinical Trials|November 10, 2019
Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosisBrian M Sandroff, M David Diggs, Marcas M Bamman, et al.The Oncologist|June 12, 2016
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Ana M Molina, Yulia Lakhman, et al.Multiple Sclerosis and Related Disorders|January 17, 2021
Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MSJohn DeLuca, Sven Schippling, Xavier Montalban, et al.The Clinical Neuropsychologist|June 10, 2016
Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS)Elizabeth S Gromisch, Vance Zemon, Roee Holtzer, et al.BMC Neurology|May 24, 2020
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.Journal of Neurology|August 20, 2020
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosisNancy D Chiaravalloti, Maria Pia Amato, Giampaolo Brichetto, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2025
Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trialsJeffrey A Cohen, Douglas L Arnold, John DeLuca, et al.Journal of Neurology|November 6, 2021
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experienceAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.Journal of Neurology|August 8, 2022
The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx studyAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.The Lancet. Neurology|September 22, 2023
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trialAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.Pageof 30